Frequency of intradialytic hypotensive episodes: old problem, new insights

Journal of the American Society of Hypertension : JASH
Ana RochaEva Xavier

Abstract

Symptomatic intradialytic hypotension (IDH) continues to be an important complication of hemodialysis treatment. There is some evidence that besides an IDH episode, repeated episodes could represent an even more important independent risk factor for mortality in hemodialysis patients. A retrospective cross-sectional study was performed to study 18 dialysis treatments in 43 patients during 6 weeks. Relationships of IDH episodes with baseline variables were examined using a Poisson regression model (generalized linear model). IDH was frequent (93% of patients) and highly variable by patient (0%-100%). Multivariate analysis showed that patients who experienced frequent hypotensive episodes had a lower dry weight (90% confidence interval [CI]: 0.95-0.99), higher phosphorus levels (90% CI: 1.07-1.47), greater prevalence of diabetes mellitus (90% CI: 1.11-2.71), and hypertension (90% CI: 1.04-2.45). Dry weight, hypertension, and phosphorus levels are modifiable risk factors to possibly reduce the rate of IDH episodes. The potential protective role of phosphorus warrants further investigation.

References

Nov 8, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·András TislérIstván Kiss
Dec 20, 2003·Journal of the American Society of Nephrology : JASN·Francesco LocatelliLucia Del Vecchio
Apr 26, 2006·Nephron. Clinical Practice·Atsushi TakedaNoriaki Matsui
Jul 1, 2008·Kidney & Blood Pressure Research·Emanuel ZittAlexander R Rosenkranz
Jan 3, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jennifer E FlytheSteven M Brunelli
Mar 12, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jennifer E FlytheSteven M Brunelli
Jun 14, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Johanna KuipersCasper F M Franssen
Jan 5, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Robert F Reilly
Jan 5, 2014·Journal of the American Society of Nephrology : JASN·Tariq ShafiUNKNOWN DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators
Jan 5, 2014·Journal of the American Society of Nephrology : JASN·Jennifer E Flythe, Steven M Brunelli
Jan 29, 2014·Hemodialysis International·Jeffrey J SandsJose A Diaz-Buxo
Nov 8, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Bergur V StefánssonNils-Olov Stålhammar

❮ Previous
Next ❯

Citations

Aug 9, 2016·International Urology and Nephrology·Ertugrul ErkenSiren Sezer
Oct 22, 2016·Seminars in Dialysis·James Tattersall
Jul 1, 2017·Seminars in Dialysis·Jason A ChouAnna T Mathew
Nov 22, 2016·JRSM Cardiovascular Disease·Ria ArnoldBruce A Pussell
Feb 16, 2018·Journal of Clinical Nursing·Ulrich SteinwandelJohan Rosman
Oct 18, 2016·Current Opinion in Nephrology and Hypertension·Ambreen GulPhilip Zager
Apr 15, 2020·Seminars in Dialysis·Timothy W R DoultonIndranil Dasgupta
Sep 29, 2020·American Journal of Physiology. Renal Physiology·Justin D SprickJeanie Park
Mar 5, 2020·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Marie Patrice HalleAshuntantang E Gloria
Jan 10, 2018·Seminars in Dialysis·John V Duronville, Clarissa J Diamantidis
Feb 13, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Hojun LeeSeung Seok Han

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.